ArticleJournal of experimental & clinical cancer research : CR2022

Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.